Semaglutide

Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist used in medical and research settings for the management of type 2 diabetes and weight-related metabolic conditions. It works by mimicking the action of the natural GLP-1 hormone, which helps regulate insulin secretion, reduce glucagon release, slow gastric emptying, and increase satiety, leading to reduced appetite and improved blood glucose control.

In clinical use, Semaglutide has been shown to support significant weight reduction and improved glycemic control when combined with diet and lifestyle interventions. It is studied extensively for its effects on metabolic health, cardiovascular risk factors, and long-term appetite regulation due to its sustained activity and once-weekly dosing profile.